AIG
EIGR

American International Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

American International Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-671
Closed -$18K – 3208
2023
Q1 		$18K Buy
671
+14
+2% +$651 ﹤0.01% 2906
2022
Q4 		$23.3K Sell
657
-3
-0.5% -$360 ﹤0.01% 2908
2022
Q3 		$149K Buy
660
+21
+3% +$5.16K ﹤0.01% 2335
2022
Q2 		$121K Buy
639
+109
+21% +$22K ﹤0.01% 2480
2022
Q1 		$132K Sell
530
-37
-7% -$5.85K ﹤0.01% 2472
2021
Q4 		$88K Sell
567
-17
-3% -$3.29K ﹤0.01% 2771
2021
Q3 		$117K Sell
584
-14
-2% -$3.33K ﹤0.01% 2734
2021
Q2 		$153 Buy
598
+4
+0.7% +$998 ﹤0.01% 2673
2021
Q1 		$158 Buy
594
+1
+0.2% +$315 ﹤0.01% 2492
2020
Q4 		$219 Buy
593
+45
+8% +$12.9K ﹤0.01% 2238
2020
Q3 		$134K Buy
548
+68
+14% +$21.2K ﹤0.01% 2366
2020
Q2 		$138K Buy
480
+17
+4% +$5.01K ﹤0.01% 2332
2020
Q1 		$94K Sell
463
-26
-5% -$8.29K ﹤0.01% 2342
2019
Q4 		$219K Sell
489
-4
-0.8% -$1.42K ﹤0.01% 2154
2019
Q3 		$152K Sell
493
-4
-0.8% -$1.3K ﹤0.01% 2360
2019
Q2 		$158K Buy
+497
New +$172K ﹤0.01% 2387
2017
Q2 		– Sell
-72
Closed -$25K – 3131
2017
Q1 		$25K Buy
72
+6
+9% +$2.07K ﹤0.01% 2941
2016
Q4 		$23K Sell
66
-1
-1% -$366 ﹤0.01% 2961
2016
Q3 		$26.7K Buy
67
+1
+2% +$510 ﹤0.01% 2986
2016
Q2 		$39.5K Buy
+66
New +$40.1K ﹤0.01% 2994
2016
Q1 		– Hold
0
– – – 5144
2015
Q4 		– Hold
0
– – – 5105
2015
Q3 		– Hold
0
– – – 5084
2015
Q2 		– Hold
0
– – – 5074

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

American International Group's EIGR Position: Q2 2023 in Review

American International Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 671 shares — an estimated $18K sold.

American International Group first reported a position in EIGR in Q2 2016 and held it in 20 quarters. The position peaked at $219K in Q4 2019. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

  • American International Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 671 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $18K.
  • American International Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2016 and held it in 20 quarters.
  • American International Group's Eiger BioPharmaceuticals, Inc. position peaked at $219K in Q4 2019.
  • 66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.